Aplastic anemia: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
Iqra Qamar (talk | contribs) No edit summary |
||
Line 21: | Line 21: | ||
}} | }} | ||
{{Template:Aplastic anemia}} | {{Template:Aplastic anemia}} | ||
{{CMG}}; Aric Hall, M.D., Beth Israel Deaconess Medical Center, Boston, MA[mailto:achall@bidmc.harvard.edu] | {{CMG}}; {{AE}} {{N.F}}; Aric Hall, M.D., Beth Israel Deaconess Medical Center, Boston, MA[mailto:achall@bidmc.harvard.edu] | ||
{{SK}} Aplastic anaemia, aplastic pancytopenia, bone marrow hypoplasia, hypoplastic bone marrow, bone marrow aplasia, aplastic bone marrow, Ehrlich anemia, Hypoplastic anemia; Refractory anemia | {{SK}} Aplastic anaemia, aplastic pancytopenia, bone marrow hypoplasia, hypoplastic bone marrow, bone marrow aplasia, aplastic bone marrow, Ehrlich anemia, Hypoplastic anemia; Refractory anemia |
Latest revision as of 16:54, 19 October 2018
Resident Survival Guide |
For patient information click here
Template:DiseaseDisorder infobox
Aplastic anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Aplastic anemia On the Web |
American Roentgen Ray Society Images of Aplastic anemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nazia Fuad M.D.; Aric Hall, M.D., Beth Israel Deaconess Medical Center, Boston, MA[2]
Synonyms and keywords: Aplastic anaemia, aplastic pancytopenia, bone marrow hypoplasia, hypoplastic bone marrow, bone marrow aplasia, aplastic bone marrow, Ehrlich anemia, Hypoplastic anemia; Refractory anemia
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Aplastic anemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies